超音波市場：技術別（2D、3D、ドップラー、造影、HIFU、ESWL）、コンポーネント別（ワークステーション、プローブ）、タイプ別（カート、ハンドヘルド、PoC）、用途別（産婦人科、CVD、泌尿器科、整形外科）、エンドユーザー別（病院、クリニック、ASCs）、地域別 - 2028年までの世界予測

Ultrasound Market by Technology (2D, 3D, Doppler, Contrast-Enhanced, HIFU, ESWL), Component (Workstation, Probe), Type (Cart, Handheld, PoC), Application (OB/GYN, CVD, Urology, Ortho), End User (Hospitals, Clinics, ASCs) & Region - Global Forecast to 2028

世界の超音波市場は、2023年の85億米ドルから2028年には116億米ドルに達すると予測され、2023年から2028年までの年平均成長率は6.3%である。対象疾患の罹患率/有病率の高さ、画像診断センター/処置の増加、疾患の... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年8月4日	US$7,150 シングルユーザライセンスライセンス・価格情報注文方法はこちら	259	218	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

世界の超音波市場は、2023年の85億米ドルから2028年には116億米ドルに達すると予測され、2023年から2028年までの年平均成長率は6.3%である。対象疾患の罹患率/有病率の高さ、画像診断センター/処置の増加、疾患の早期診断の利点に関する意識の高まり、技術的に先進的な超音波機能とモダリティの急速な採用などの要因が、この市場の成長拡大の要因となっている。

"診断超音波の2D診断超音波サブシステム分野が2022年に市場で最大のシェアを占めた"
技術に基づき、超音波市場は診断用超音波、治療用超音波、造影強化超音波に区分される。超音波診断セグメントは、さらに2D、3D、4D、ドプラ、造影超音波に分けられる。2Dサブセグメントが市場の主要シェアを占めている。2D超音波が提供するリアルタイムイメージング、非侵襲的処置、高画像解像度、携帯性とともに容易なアクセスなどの利点が、この製品セグメントの成長を促進している。

"携帯性セグメントは予測期間中に最も高いCAGRを記録すると予測されている"
携帯性に基づいて、超音波市場はトロリー/カートベース超音波、コンパクト/ハンドヘルド超音波、ポイントオブケア（PoC）超音波に区分される。トロリー/カートベースの超音波セグメントは、2022年に最大の市場シェアを占めた。このセグメントの大きなシェアは、システムの多用途性、画質、高度な機能、使いやすさ、病院や医療機関における急性期医療や救急医療での使用の増加によるものである。

「ディスプレイ分野は予測期間中に最も高いCAGRを記録すると予測されている。
超音波市場は、装置のディスプレイをベースに、白黒超音波装置とカラー超音波装置に区分される。カラー超音波装置セグメントは、2020年の超音波市場で最大のシェアを占めている。これは、カラー超音波デバイスが提供するメリット（より良い画質、より高い画像解像度など）、先進的なカラー超音波デバイスの市場における入手可能性の拡大（主要国における製品コストの継続的な低下と相まって）、新興国における主要メーカーの流通網の拡大などの要因によるものと考えられる。
"北米地域の市場は予測期間中に最も高い成長を目撃する見込み"
北米地域の超音波市場は、予測期間中にCAGRを記録すると予想されている。主な理由は、同地域の医療費の高騰、対象疾患の有病率の上昇、研究活動の増加、美容手術の増加、イメージングシステムの技術進歩などである。

本レポートで参照した主要参入企業の内訳は以下の通り：
- 企業タイプ別Tier1-48％、Tier2-36％、Tier3-16
- 役職別ディレクターレベル-14%、Cレベル-10%、その他-76
- 地域別北米-40%、欧州-32%、アジア太平洋地域-20%、中南米-5%、中東・アフリカ-3

超音波市場の主要プレーヤーは、GEヘルスケア（米国）、Koninklijke Philips N.V.（オランダ）、キヤノンメディカルシステムズ（日本）、シーメンスAG（ドイツ）、ホロジック（米国）、富士フイルムホールディングス（日本）、サムスン電子（日本）、Mindray Medical Co.(日本）、Mindray Medical International Limited（中国）などがある。

調査範囲

本レポートでは、超音波市場を技術、ディスプレイ、携帯性、コンポーネント、アプリケーション、エンドユーザー、地域別に調査しています。また、市場成長に影響を与える要因を網羅し、市場における様々な機会と課題を分析し、市場リーダー向けに競争状況の詳細を提供しています。さらに、本レポートでは、ミクロ市場の成長動向を分析し、主要5地域（およびこれらの地域の各国）に関する市場セグメントの収益を予測しています。

レポート購入の理由
本レポートは、超音波市場全体とサブセグメントの収益数の最も近い近似値に関する情報を提供し、市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、自社のビジネスをより良く位置づけ、適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、本レポートは、関係者が市場の脈動を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供するのに役立ちます。

本レポートは、以下のポイントに関する洞察を提供します：
- 超音波市場の成長に影響を与える主な促進要因（対象患者数の増加、マルチモーダルPETイメージング装置の採用拡大、技術進歩、官民組織による投資・資金・助成金の増加）、抑制要因（資本コストと運用コストの高さ、不利な規制ガイドライン）、機会（新興国における医療インフラの改善、乳房イメージングにおけるPETの利用、有望な製品パイプライン）、課題（代替イメージング技術の利用可能性）の分析
- 製品開発/イノベーション：超音波市場における今後の技術、研究開発活動、新製品・サービス発表に関する詳細な洞察
- 市場開発：有利な市場に関する包括的な情報-様々な地域の超音波市場を分析しています。
- 市場の多様化：超音波市場における新製品、未開拓地域、最近の開発、投資に関する詳細情報
- 競合評価：GE Healthcare（米国）、Koninklijke Philips N.V.（オランダ）、キヤノンメディカルシステムズ株式会社（日本）、Siemens AG（ドイツ）、Hologic, Inc.（米国）、富士フイルム株式会社（日本）、サムスン電子株式会社（日本）、Mindray Medical Co.(日本）、Mindray Medical International Limited（中国）

ページTOPに戻る

1 INTRODUCTION 20
1.1 STUDY OBJECTIVES 20
1.2 MARKET DEFINITION 20
1.2.1 INCLUSIONS AND EXCLUSIONS 21
1.3 STUDY SCOPE 22
1.3.1 MARKETS COVERED 22
1.3.2 REGIONS COVERED 23
1.3.3 YEARS CONSIDERED 23
1.3.4 CURRENCY CONSIDERED 23
1.4 RESEARCH LIMITATIONS 24
1.5 STAKEHOLDERS 24
1.6 SUMMARY OF CHANGES 25
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH DATA 26
FIGURE 1 ULTRASOUND MARKET: RESEARCH DESIGN 26
2.1.1 SECONDARY RESEARCH 27
2.1.2 PRIMARY RESEARCH 29
2.1.2.1 Primary sources 29
2.1.2.2 Key industry insights 30
2.1.2.3 Breakdown of primaries 30
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 30
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 31
2.2 MARKET SIZE ESTIMATION 31
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 32
2.2.1 BOTTOM-UP APPROACH 32
2.2.1.1 Approach 1: Company revenue estimation approach 33
FIGURE 5 MARKET SIZE ESTIMATION FOR ULTRASOUND MARKET: APPROACH 1 (COMPANY REVENUE ESTIMATION) 33
FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF GE HEALTHCARE 34
2.2.1.2 Approach 2: Customer-based market estimation 34
2.2.1.3 Ultrasound market: Top-down approach 35
2.2.1.4 CAGR projection 35
FIGURE 7 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 35
2.3 DATA VALIDATION APPROACH 36
FIGURE 8 DATA TRIANGULATION METHODOLOGY 36

2.4 MARKET SHARE ASSESSMENT 37
2.5 STUDY ASSUMPTIONS 37
2.6 RISK ASSESSMENT 37
2.6.1 ULTRASOUND MARKET: RISK ASSESSMENT 37
2.7 GROWTH RATE ASSUMPTIONS 38
2.8 ULTRASOUND MARKET: RECESSION IMPACT 38
3 EXECUTIVE SUMMARY 39
FIGURE 9 ULTRASOUND MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 39
FIGURE 10 ULTRASOUND MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 40
FIGURE 11 ULTRASOUND MARKET, BY PORTABILITY, 2023 VS. 2028 (USD MILLION) 41
FIGURE 12 ULTRASOUND MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 41
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF ULTRASOUND MARKET 42
4 PREMIUM INSIGHTS 43
4.1 ULTRASOUND MARKET OVERVIEW 43
FIGURE 14 INCREASING INCIDENCE OF TARGET DISEASES AND SUBSEQUENT RISE IN SURGICAL PROCEDURES TO DRIVE MARKET 43
4.2 EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY (USD MILLION) 44
FIGURE 15 DIAGNOSTIC ULTRASOUND SEGMENT TO HOLD LARGEST SHARE 44
4.3 ASIA PACIFIC: ULTRASOUND MARKET, BY END USER 44
FIGURE 16 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 44
4.4 ULTRASOUND MARKET, BY DISPLAY TYPE 45
FIGURE 17 COLOR ULTRASOUND SEGMENT TO COMMAND LARGEST SHARE TILL 2028 45
4.5 GEOGRAPHIC SNAPSHOT OF ULTRASOUND MARKET 45
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 45
5 MARKET OVERVIEW 46
5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 46
FIGURE 19 ULTRASOUND MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
5.2.1 DRIVERS 47
5.2.1.1 Increasing incidence of target diseases and subsequent rise in surgical procedures 47
5.2.1.2 Growing patient preference for minimally invasive surgeries 48
5.2.1.3 Rising technological advancements in ultrasound devices 48
5.2.1.4 Growing public-private investments for product commercialization 49
5.2.1.5 Increasing establishment of hospitals and diagnostic centers 50
5.2.2 RESTRAINTS 50
5.2.2.1 Unfavorable reimbursements 50
5.2.2.2 High operating costs 51
5.2.3 OPPORTUNITIES 51
5.2.3.1 Growing applications of therapeutic ultrasound 51
5.2.3.2 High growth potential of emerging markets 52
5.2.3.3 Development of POC ultrasound systems 52
5.2.4 CHALLENGES 53
5.2.4.1 Growing end-user preference for refurbished equipment 53
5.2.4.2 Shortage of skilled sonographers 53
5.3 PORTER’S FIVE FORCES ANALYSIS 53
TABLE 1 ULTRASOUND MARKET: PORTER’S FIVE FORCES ANALYSIS 53
5.3.1 THREAT OF NEW ENTRANTS 54
5.3.2 THREAT OF SUBSTITUTES 54
5.3.3 BARGAINING POWER OF SUPPLIERS 54
5.3.4 BARGAINING POWER OF BUYERS 54
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 54
5.4 REGULATORY TRENDS 55
5.5 REGULATORY ANALYSIS 55
5.5.1 NORTH AMERICA 55
5.5.1.1 US 55
TABLE 2 US FDA: MEDICAL DEVICE CLASSIFICATION 56
TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 56
5.5.1.2 Canada 56
TABLE 4 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 57
5.5.2 EUROPE 57
5.5.3 ASIA PACIFIC 58
5.5.3.1 Japan 58
TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 58
5.5.3.2 China 59
TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES 59
5.5.3.3 India 60
5.6 REIMBURSEMENT SCENARIO 61
TABLE 7 MEDICAL REIMBURSEMENT CPT CODES FOR ULTRASOUND PROCEDURES IN US (AS OF 2021) 61
5.7 ECOSYSTEM MAPPING 62
5.8 VALUE CHAIN ANALYSIS 62
5.8.1 RESEARCH & PRODUCT DEVELOPMENT 62
5.8.2 RAW MATERIAL AND MANUFACTURING 62
5.8.3 MARKETING & SALES, SHIPMENT, AND POST-SALES SERVICES 62
FIGURE 20 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE 63
5.9 SUPPLY CHAIN ANALYSIS 63
5.9.1 PROMINENT COMPANIES 63
5.9.2 SMALL & MEDIUM-SIZED ENTERPRISES 63
5.9.3 END USERS 63
TABLE 8 ULTRASOUND MARKET: SUPPLY CHAIN ECOSYSTEM 64
FIGURE 21 ULTRASOUND MARKET: SUPPLY CHAIN ANALYSIS 65
5.10 PATENT ANALYSIS 66
FIGURE 22 PATENT DETAILS FOR ULTRASOUND (JANUARY 2013–JUNE 2023) 66
FIGURE 23 PATENTS FOR DIAGNOSTIC ULTRASOUND SYSTEMS (JANUARY 2013–JUNE 2023) 67
FIGURE 24 PATENTS FOR THERAPEUTIC ULTRASOUND SYSTEMS (JANUARY 2013–JUNE 2023) 68
5.11 TRADE ANALYSIS 69
5.11.1 ULTRASOUND MARKET: TRADE ANALYSIS 69
TABLE 9 IMPORT DATA FOR ULTRASOUND SYSTEMS (HS CODE 901812), BY COUNTRY, 2018–2022 (USD) 69
TABLE 10 EXPORT DATA FOR ULTRASOUND SYSTEMS (HS CODE 901812), BY COUNTRY, 2018–2022 (USD) 69
5.12 KEY CONFERENCES AND EVENTS 70
TABLE 11 ULTRASOUND MARKET: LIST OF KEY CONFERENCES AND EVENTS (2023–2025) 70
5.13 TECHNOLOGY ANALYSIS 71
5.14 CASE STUDY ANALYSIS 72
TABLE 12 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE 72
TABLE 13 CASE STUDY 2: PROVIDING COMPREHENSIVE TRAINING PROGRAMS FOR EVOLVING ULTRASOUND TECHNIQUES 73
5.15 PRICING ANALYSIS 73
TABLE 14 REGIONAL PRICE RANGE FOR ULTRASOUND SYSTEMS 73
6 ULTRASOUND MARKET, BY TECHNOLOGY 74
6.1 INTRODUCTION 75
TABLE 15 ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 75
6.2 DIAGNOSTIC ULTRASOUND 75
TABLE 16 DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 76
TABLE 17 DIAGNOSTIC ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION) 76
TABLE 18 DIAGNOSTIC ULTRASOUND MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION) 77
TABLE 19 DIAGNOSTIC ULTRASOUND MARKET, BY PORTABILITY, 2021–2028 (USD MILLION) 77
TABLE 20 DIAGNOSTIC ULTRASOUND MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 78
TABLE 21 DIAGNOSTIC ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION) 78
6.2.1 2D ULTRASOUND 79
6.2.1.1 Strong demand in emerging economies to drive market 79
TABLE 22 2D ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION) 79
6.2.2 3D & 4D ULTRASOUND 80
6.2.2.1 Greater diagnostic accuracy and improved imaging capabilities to boost demand 80
TABLE 23 3D & 4D ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION) 80
6.2.3 DOPPLER ULTRASOUND 80
6.2.3.1 Growing applications in pain management, cardiovascular imaging, and emergency care to drive market 80
TABLE 24 DOPPLER ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION) 81
6.2.4 CONTRAST-ENHANCED ULTRASOUND 81
6.2.4.1 Availability of technologically advanced instruments to support growth 81
TABLE 25 CONTRAST-ENHANCED ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION) 82
6.3 THERAPEUTIC ULTRASOUND 82
TABLE 26 THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 82
TABLE 27 THERAPEUTIC ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 28 THERAPEUTIC ULTRASOUND MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION) 83
TABLE 29 THERAPEUTIC ULTRASOUND MARKET, BY PORTABILITY, 2021–2028 (USD MILLION) 83
TABLE 30 THERAPEUTIC ULTRASOUND MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 84
TABLE 31 THERAPEUTIC ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION) 84
6.3.1 HIGH-INTENSITY FOCUSED ULTRASOUND 85
6.3.1.1 Promising results associated with HIFU in cancer treatment to drive market 85
TABLE 32 HIGH-INTENSITY FOCUSED ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION) 85
6.3.2 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY 86
6.3.2.1 Growing emphasis on minimally invasive treatment of kidney & gallbladder stones to drive demand for ESWL 86
TABLE 33 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY MARKET, BY REGION, 2021–2028 (USD MILLION) 86
7 ULTRASOUND MARKET, BY DISPLAY 87
7.1 INTRODUCTION 88
TABLE 34 ULTRASOUND MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION) 88
7.2 COLOR ULTRASOUND DEVICES 88
7.2.1 RISING AVAILABILITY OF ADVANCED COLOR ULTRASOUND DEVICES TO DRIVE MARKET 88
TABLE 35 COLOR ULTRASOUND DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 89
7.3 BLACK & WHITE ULTRASOUND DEVICES 89
7.3.1 ASIA PACIFIC REGION TO SHOW SUSTAINED DEMAND 89
TABLE 36 BLACK & WHITE ULTRASOUND DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 90
8 ULTRASOUND MARKET, BY PORTABILITY 91
8.1 INTRODUCTION 92
TABLE 37 ULTRASOUND MARKET, BY PORTABILITY, 2021–2028 (USD MILLION) 92
8.2 TROLLEY/CART-BASED ULTRASOUND SYSTEMS 92
8.2.1 RISING USAGE OF TROLLEY-BASED SYSTEMS IN ACUTE & EMERGENCY CARE TO DRIVE MARKET 92
TABLE 38 TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 93
8.3 COMPACT/HANDHELD ULTRASOUND SYSTEMS 93
8.3.1 AFFORDABILITY AND PROCEDURAL & TECHNICAL BENEFITS TO DRIVE MARKET 93
TABLE 39 COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 94
8.4 POC ULTRASOUND SYSTEMS 94
8.4.1 IMPROVED OPERATIONAL AND CLINICAL EFFICACY TO BOOST DEMAND 94
TABLE 40 POC ULTRASOUND SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 95
9 ULTRASOUND MARKET, BY APPLICATION 96
9.1 INTRODUCTION 97
TABLE 41 ULTRASOUND MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 97
9.2 RADIOLOGICAL/GENERAL IMAGING APPLICATIONS 97
9.2.1 GROWING NUMBER OF IMAGE-GUIDED SURGERIES TO DRIVE MARKET 97
TABLE 42 ULTRASOUND MARKET FOR RADIOLOGICAL/GENERAL IMAGING APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 98
9.3 CARDIOLOGICAL APPLICATIONS 98
9.3.1 RISING PREVALENCE OF CARDIAC DISORDERS TO DRIVE MARKET 98
TABLE 43 ULTRASOUND MARKET FOR CARDIOLOGICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 99
9.4 OBSTETRIC/GYNECOLOGICAL APPLICATIONS 99
9.4.1 WIDE USAGE IN OB/GYN APPLICATIONS TO BOOST GROWTH 99
TABLE 44 ULTRASOUND MARKET FOR OBSTETRIC/GYNECOLOGICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 100
9.5 UROLOGICAL APPLICATIONS 100
9.5.1 GROWING PREVALENCE OF UROLOGICAL DISORDERS TO SUPPORT MARKET 100
TABLE 45 ULTRASOUND MARKET FOR UROLOGICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 101
9.6 VASCULAR APPLICATIONS 101
9.6.1 VASCULAR APPLICATIONS TO WITNESS HIGH GROWTH 101
TABLE 46 ULTRASOUND MARKET FOR VASCULAR APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 102
9.7 ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS 102
9.7.1 RISING PATIENT PREFERENCE FOR EARLY DIAGNOSIS TO DRIVE MARKET 102
TABLE 47 ULTRASOUND MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 103
9.8 PAIN MANAGEMENT APPLICATIONS 103
9.8.1 INCREASING USE IN TRAUMA & EMERGENCY CARE TO SUPPORT MARKET GROWTH 103
TABLE 48 ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 104
9.9 OTHER APPLICATIONS 104
TABLE 49 ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 104
10 ULTRASOUND MARKET, BY COMPONENT 105
10.1 INTRODUCTION 106
TABLE 50 ULTRASOUND MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 106
10.2 TRANSDUCERS/PROBES 106
TABLE 51 ULTRASOUND TRANSDUCERS/PROBES MARKET, BY TYPE, 2021–2028 (USD MILLION) 107
TABLE 52 ULTRASOUND TRANSDUCERS/PROBES MARKET, BY REGION, 2021–2028 (USD MILLION) 107
10.2.1 CURVILINEAR/CONVEX ARRAYS 107
10.2.1.1 Growing adoption of POC ultrasound to support growth 107
TABLE 53 CURVILINEAR/CONVEX ARRAYS MARKET, BY REGION, 2021–2028 (USD MILLION) 108
10.2.2 LINEAR ARRAYS 108
10.2.2.1 Rising target patient population to drive market 108
TABLE 54 LINEAR ARRAYS MARKET, BY REGION, 2021–2028 (USD MILLION) 108
10.2.3 PHASED ARRAYS 109
10.2.3.1 Technological advancements to drive market 109
TABLE 55 PHASED ARRAYS MARKET, BY REGION, 2021–2028 (USD MILLION) 109
10.2.4 OTHER ARRAY TYPES 109
TABLE 56 OTHER ARRAY TYPES MARKET, BY REGION, 2021–2028 (USD MILLION) 110
10.3 WORKSTATIONS 110
10.3.1 GROWING DIAGNOSTIC PROCEDURAL VOLUMES TO FUEL DEMAND FOR WORKSTATIONS 110
TABLE 57 ULTRASOUND WORKSTATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 110
10.4 OTHER COMPONENTS 111
TABLE 58 OTHER ULTRASOUND COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 111
11 ULTRASOUND MARKET, BY END USER 112
11.1 INTRODUCTION 113
TABLE 59 ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION) 113
11.2 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS 113
11.2.1 HIGH PROCEDURAL VOLUMES TO ENSURE SUSTAINED DEMAND FOR ULTRASOUND 113
TABLE 60 ULTRASOUND MARKET FOR HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION) 114
11.3 MATERNITY CENTERS 114
11.3.1 INCREASED ADOPTION OF ADVANCED ULTRASOUND FOR OB/GYN APPLICATIONS TO BOOST GROWTH 114
TABLE 61 ULTRASOUND MARKET FOR MATERNITY CENTERS, BY REGION, 2021–2028 (USD MILLION) 115
11.4 AMBULATORY CARE CENTERS 115
11.4.1 INCREASING EMPHASIS ON AMBULATORY CARE TO SUPPORT MARKET GROWTH 115
TABLE 62 ULTRASOUND MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2021–2028 (USD MILLION) 116
11.5 RESEARCH & ACADEMIA 116
11.5.1 GROWING AVAILABILITY OF RESEARCH GRANTS & FUNDING TO DRIVE GROWTH 116
TABLE 63 ULTRASOUND MARKET FOR RESEARCH & ACADEMIA, BY REGION, 2021–2028 (USD MILLION) 117
11.6 OTHER END USERS 117
TABLE 64 ULTRASOUND MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 118
12 ULTRASOUND MARKET, BY REGION 119
12.1 INTRODUCTION 120
TABLE 65 ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION) 120
12.2 NORTH AMERICA 121
FIGURE 25 NORTH AMERICA: ULTRASOUND MARKET SNAPSHOT 121
TABLE 66 NORTH AMERICA: ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 67 NORTH AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 122
TABLE 68 NORTH AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 69 NORTH AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 70 NORTH AMERICA: ULTRASOUND MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION) 123
TABLE 71 NORTH AMERICA: ULTRASOUND MARKET, BY PORTABILITY, 2021–2028 (USD MILLION) 123
TABLE 72 NORTH AMERICA: ULTRASOUND MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 124
TABLE 73 NORTH AMERICA: ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION) 124
12.2.1 US 125
12.2.1.1 Advanced healthcare infrastructure and favorable regulations to drive market 125
TABLE 74 POCUS ULTRASOUND CPT CODES (2021) 125
TABLE 75 US: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 129
TABLE 76 US: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 130
TABLE 77 US: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 130
12.2.2 CANADA 130
12.2.2.1 Growing awareness about early disease diagnosis to drive market 130
TABLE 78 CANADA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 131
TABLE 79 CANADA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 80 CANADA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 132
12.3 EUROPE 132
TABLE 81 EUROPE: ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 82 EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 133
TABLE 83 EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 84 EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 85 EUROPE: ULTRASOUND MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION) 134
TABLE 86 EUROPE: ULTRASOUND MARKET, BY PORTABILITY, 2021–2028 (USD MILLION) 134
TABLE 87 EUROPE: ULTRASOUND MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 135
TABLE 88 EUROPE: ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION) 135
12.3.1 GERMANY 136
12.3.1.1 Increasing healthcare expenditure and government spending to drive market 136
TABLE 89 GERMANY: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 137
TABLE 90 GERMANY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 91 GERMANY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
12.3.2 FRANCE 138
12.3.2.1 Increasing target patient population and rising number of diagnostic tests for chronic diseases to drive market 138
TABLE 92 FRANCE: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 139
TABLE 93 FRANCE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 139
TABLE 94 FRANCE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 139
12.3.3 UK 140
12.3.3.1 Growing government initiatives and increasing incidences of chronic diseases to drive market 140
TABLE 95 UK: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 140
TABLE 96 UK: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 97 UK: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
12.3.4 ITALY 141
12.3.4.1 Increased availability of reimbursement coverage for diagnostic procedures to drive market 141
TABLE 98 ITALY: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 142
TABLE 99 ITALY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 100 ITALY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
12.3.5 SPAIN 143
12.3.5.1 Increasing prevalence of cancer and growing private-public funding to drive market 143
TABLE 101 SPAIN: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 144
TABLE 102 SPAIN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 103 SPAIN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 145
12.3.6 REST OF EUROPE 145
TABLE 104 REST OF EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 146
TABLE 105 REST OF EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 106 REST OF EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 146
12.4 ASIA PACIFIC 147
FIGURE 26 ASIA PACIFIC: ULTRASOUND MARKET SNAPSHOT 147
TABLE 107 ASIA PACIFIC: ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 108 ASIA PACIFIC: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 148
TABLE 109 ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 110 ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 111 ASIA PACIFIC: ULTRASOUND MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION) 149
TABLE 112 ASIA PACIFIC: ULTRASOUND MARKET, BY PORTABILITY, 2021–2028 (USD MILLION) 150
TABLE 113 ASIA PACIFIC: ULTRASOUND MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 114 ASIA PACIFIC: ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION) 151
12.4.1 CHINA 151
12.4.1.1 Increasing healthcare reforms and rising government investments to drive market 151
TABLE 115 CHINA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 152
TABLE 116 CHINA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 117 CHINA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
12.4.2 JAPAN 153
12.4.2.1 Fast adoption of advanced technologies and growth in geriatric population to drive market 153
TABLE 118 JAPAN: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 154
TABLE 119 JAPAN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 120 JAPAN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
12.4.3 INDIA 155
12.4.3.1 Increasing number of diagnostic procedures and improving healthcare infrastructure to drive market 155
TABLE 121 INDIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 156
TABLE 122 INDIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 123 INDIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
12.4.4 AUSTRALIA 157
12.4.4.1 Growing healthcare spending and increasing investments in research to drive market 157
TABLE 124 AUSTRALIA: ULTRASOUND REIMBURSEMENT SCENARIO 158
TABLE 125 AUSTRALIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 161
TABLE 126 AUSTRALIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 127 AUSTRALIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
12.4.5 SOUTH KOREA 162
12.4.5.1 Well-developed healthcare system and rising awareness of diseases to drive market 162
TABLE 128 SOUTH KOREA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 163
TABLE 129 SOUTH KOREA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 130 SOUTH KOREA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
12.4.6 REST OF ASIA PACIFIC 164
TABLE 131 REST OF ASIA PACIFIC: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 165
TABLE 132 REST OF ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 133 REST OF ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
12.5 LATIN AMERICA 166
TABLE 134 LATIN AMERICA: ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 135 LATIN AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 167
TABLE 136 LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 137 LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 138 LATIN AMERICA: ULTRASOUND MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION) 168
TABLE 139 LATIN AMERICA: ULTRASOUND MARKET, BY PORTABILITY, 2021–2028 (USD MILLION) 168
TABLE 140 LATIN AMERICA: ULTRASOUND MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 169
TABLE 141 LATIN AMERICA: ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION) 169
12.5.1 BRAZIL 170
12.5.1.1 Greater purchasing power and favorable demographic conditions to drive market 170
TABLE 142 BRAZIL: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 170
TABLE 143 BRAZIL: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 144 BRAZIL: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
12.5.2 MEXICO 172
12.5.2.1 Increased medical tourism and better government healthcare initiatives to drive market 172
TABLE 145 MEXICO: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 172
TABLE 146 MEXICO: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 147 MEXICO: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
12.5.3 REST OF LATIN AMERICA 173
TABLE 148 REST OF LATIN AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 174
TABLE 149 REST OF LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 150 REST OF LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
12.6 MIDDLE EAST & AFRICA 175
12.6.1 GROWING MEDICAL TOURISM AND INCREASING QUALITY HEALTHCARE SYSTEMS TO DRIVE MARKET 175
TABLE 151 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 176
TABLE 152 MIDDLE EAST & AFRICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 153 MIDDLE EAST & AFRICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 154 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION) 177
TABLE 155 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY PORTABILITY, 2021–2028 (USD MILLION) 178
TABLE 156 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 178
TABLE 157 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION) 179
13 COMPETITIVE LANDSCAPE 180
13.1 OVERVIEW 180
13.2 STRATEGIES ADOPTED BY KEY PLAYERS 180
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ULTRASOUND MARKET 180
13.3 REVENUE SHARE ANALYSIS 181
FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN ULTRASOUND MARKET, 2022 181
13.4 MARKET SHARE ANALYSIS 181
FIGURE 28 MARKET SHARE ANALYSIS OF TOP PLAYERS IN ULTRASOUND MARKET, 2022 182
TABLE 158 ULTRASOUND MARKET: DEGREE OF COMPETITION 182
13.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 184
13.5.1 STARS 184
13.5.2 EMERGING LEADERS 184
13.5.3 PERVASIVE PLAYERS 184
13.5.4 PARTICIPANTS 184
FIGURE 29 ULTRASOUND MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 185
13.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 186
13.6.1 PROGRESSIVE COMPANIES 186
13.6.2 STARTING BLOCKS 186
13.6.3 RESPONSIVE COMPANIES 186
13.6.4 DYNAMIC COMPANIES 186
FIGURE 30 ULTRASOUND MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 187
13.7 COMPETITIVE BENCHMARKING 188
TABLE 159 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS 188
TABLE 160 PRODUCT FOOTPRINT ANALYSIS 188
TABLE 161 REGIONAL FOOTPRINT ANALYSIS 189
13.8 COMPETITIVE SCENARIO AND TRENDS 190
TABLE 162 PRODUCT LAUNCHES, JANUARY 2020–JUNE 2023 190
TABLE 163 DEALS, JANUARY 2020–JUNE 2023 191
TABLE 164 OTHER DEVELOPMENTS, JANUARY 2020–JUNE 2023 192
14 COMPANY PROFILES 193
14.1 KEY PLAYERS 193
(Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)*
14.1.1 GE HEALTHCARE 193
TABLE 165 GE HEALTHCARE: COMPANY OVERVIEW 193
FIGURE 31 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 194
14.1.2 KONINKLIJKE PHILIPS N.V. 198
TABLE 166 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 198
FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 199
14.1.3 CANON MEDICAL SYSTEMS CORPORATION 202
TABLE 167 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 202
FIGURE 33 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2022) 203
14.1.4 SIEMENS AG 206
TABLE 168 SIEMENS AG: COMPANY OVERVIEW 206
FIGURE 34 SIEMENS AG: COMPANY SNAPSHOT (2022) 207
14.1.5 FUJIFILM CORPORATION 209
TABLE 169 FUJIFILM CORPORATION: COMPANY OVERVIEW 209
FIGURE 35 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2022) 210
14.1.6 HOLOGIC, INC. 214
TABLE 170 HOLOGIC, INC.: COMPANY OVERVIEW 214
FIGURE 36 HOLOGIC, INC.: COMPANY SNAPSHOT (2022) 215
14.1.7 SAMSUNG ELECTRONICS CO., LTD. 217
TABLE 171 SAMSUNG ELECTRONICS CO., LTD.: COMPANY OVERVIEW 217
FIGURE 37 SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2021) 218
14.1.8 MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 221
TABLE 172 MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 221
FIGURE 38 MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2021) 222
14.1.9 ESAOTE SPA 226
TABLE 173 ESAOTE SPA: COMPANY OVERVIEW 226
14.1.10 CHISON MEDICAL TECHNOLOGIES CO., LTD. 230
TABLE 174 CHISON MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW 230
14.1.11 NEUSOFT CORPORATION 233
TABLE 175 NEUSOFT CORPORATION: COMPANY OVERVIEW 233
FIGURE 39 NEUSOFT CORPORATION: COMPANY SNAPSHOT (2022) 234
14.1.12 MOBISANTE, INC. 235
TABLE 176 MOBISANTE, INC.: COMPANY OVERVIEW 235
14.1.13 CLARIUS 236
TABLE 177 CLARIUS: COMPANY OVERVIEW 236

14.1.14 MEDGYN PRODUCTS, INC. 238
TABLE 178 MEDGYN PRODUCTS, INC.: COMPANY OVERVIEW 238
14.1.15 PROMED TECHNOLOGY CO., LTD. 240
TABLE 179 PROMED TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 240
*Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
14.2 OTHER COMPANIES 242
14.2.1 WHITE EAGLE SONIC TECHNOLOGIES, INC. 242
14.2.2 TELEMED ULTRASOUND 243
14.2.3 SHENZHEN RICSO TECHNOLOGY CO., LTD. 244
14.2.4 GUANGDONG YOUKEY MEDICAL CO., LTD. 245
14.2.5 ECHONOUS INC. 245
14.2.6 SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT CO., LTD. 246
14.2.7 SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENTS CO., LTD. (SIUI) 247
14.2.8 BUTTERFLY NETWORK, INC. 248
14.2.9 ALPINION MEDICAL SYSTEMS CO., LTD. 249
14.2.10 EDAN INSTRUMENTS, INC. 250
15 APPENDIX 251
15.1 DISCUSSION GUIDE 251
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 254
15.3 CUSTOMIZATION OPTIONS 256
15.4 RELATED REPORTS 256
15.5 AUTHOR DETAILS 257

ページTOPに戻る

Table of Contents

Summary

The global ultrasound market is projected to reach USD 11.6 billion by 2028 from USD 8.5 billion in 2023, at a CAGR of 6.3% from 2023 to 2028. Factors such as the high incidence/prevalence of target diseases, the growing number of diagnostic imaging centers/procedures, increasing awareness about the benefits of early diagnosis of diseases, and the rapid adoption of technologically advanced ultrasound features and modalities are responsible for the increasing growth of this market.

“The 2D diagnostic ultrasound sub-systems segment of diagnostic ultrasound held the largest share of the market in 2022”
Based on technology, the ultrasound market is segmented into diagnostic ultrasound, therapeutic ultrasound, and contrast enhanced ultrasound. The diagnostic ultrasound segment of the market is further divided into 2D, 3D, 4D, doppler, and contrast enhanced ultrasound. The 2D subsegment held a major share of the market. Advantages offered by 2D ultrasound, such as real time imaging, non-invasive procedure, high-image resolution, and easy accessibility along with portability are driving the growth of this product segment.

“The portability segment is projected to register the highest CAGR during the forecast period”
Based on portability, the ultrasound market is segmented into trolley/cart-based ultrasound, compact/handheld ultrasound, and point-of-care (PoC) ultrasound. The trolley/cart-based ultrasound segment accounted for the largest market share in 2022. The large share of this segment is attributed to the system’s versatility, image quality, ehanced, easy to use features, and due to the increased usage of it in acute care settings and emergency care in hospitals and healthcare institutions.

“The display segment is projected to register the highest CAGR during the forecast period”
On the basis of device display, the ultrasound market is segmented into black & white ultrasound and color ultrasound devices. The color ultrasound devices segment accounted for the largest share of the ultrasound market in 2020. This can be attributed to factors such as benefits offered by color ultrasound devices (including better image quality and higher image resolution), growing market availability of advanced color ultrasound devices (coupled with continuous decline in product cost across major countries), and expanding distribution networks of major manufacturers across emerging countries.
“The market in the North America region is expected to witness the highest growth during the forecast period.”
The ultrasound market in the North America region is expected to register a CAGR during the forecast period, primarily due to the high healthcare spending in the region, rising prevalence of target diseases, increasing research activities, growing number of cosmetic surgeries, and technological advancements in imaging systems.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
• By Designation: Director-level–14%, C-level–10%, and Others–76%
• By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%

The prominent players in the ultrasound market are GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Siemens AG (Germany), Hologic, Inc. (US), FUJIFILM Holdings Corporation (Japan), Samsung Electronics Co., Ltd. (Japan), and Mindray Medical International Limited (China), among others.

Research Coverage

This report studies the ultrasound market based on technology, display, portability, component, application, enduser, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall ultrasound market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:
• Analysis of key drivers (rising target patient population, growing adoption of multimodal PET imaging devices, technological advancement, and increasing investment, funds, and grants by public-private organizations), restraints (high capital and operational cost, unfavorable regulatory guidelines), opportunities (improving healthcare infrastructure across emerging countries, PET utilization for breast imaging, promising product pipeline), and challenges (availability of alternate imaging technologies) influencing the growth of the ultrasound market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the ultrasound market
• Market Development: Comprehensive information about lucrative markets–the report analyses the ultrasound market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the ultrasound market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Siemens AG (Germany), Hologic, Inc. (US), FUJIFILM Corporation (Japan), Samsung Electronics Co., Ltd. (Japan), and Mindray Medical International Limited (China)

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（doppler）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（doppler）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?